Author:  Troy Lacey and Avery Foley on August 2, 2017

Source: https://answersingenesis.org/sanctity-of-life/stem-cells/colon-grown-adult-stem-cells/

A recent ScienceDaily article highlighted groundbreaking research from the Cincinnati Children’s Hospital.1 Cincinnati Children’s, located just north of the Creation Museum, is ranked number three on the Best Children’s Hospitals Honor Roll.

Children’s Hospital researchers grew human colon organoids (simplified organs from just a few stem cells).2 This is the first time that colon organoids have been successfully engineered. While other parts of the gastrointestinal tract have been grown from human pluripotent stem cells (hPSCs),3 the colon had been resistant to engineering attempts.

The (Complicated) Process of Growing an Organoid

The Children’s Hospital team performed a series of genetic screens on various lab animal embryos, looking for developing hindgut tissues (the tissue in animal and human embryos that gives rise to the colon). They also combed through medical databases to identify molecular markers for the human colon. This led to the discovery that the SATB24 protein was highly associated with hindgut tissue in mice, frogs, and humans. They also found that the BMP. 5 growth factor increased the expression of the SATB2 protein.


When researchers added BMP protein in human stem-cell-derived gut tube cultures for three days, it induced a posterior HOX code. HOX proteins are critical in helping control the embryo's development plan. In the hPSCs, the HOX code activated a series of genes that helped them develop into human colon organoids. These cells were then injected into immunosuppressed mice for 6–10 weeks. Following the transplant, researchers noted that the organoids assumed the form, structures, and molecular and cell properties of the human colon.

“Very Relevant” Research for Those with GI Tract Conditions

One of the lead researchers, Jorge Múnera, PhD, was quoted in the study: "By exposing human colonic organoids to inflammatory triggers, we can now learn how the cell lining of the colon and the supporting cells beneath cooperate to respond to inflammation," Múnera said. "This could be very relevant for patients with Crohn's disease or ulcerative colitis. And because of the microbiome, the organisms that live in our guts, are most concentrated in the colon, the organoids potentially could be used to model the human microbiome in health and disease."

GI tract conditions and diseases afflict 60–70 million Americans6 with some 20 million cases being chronic.7 The numbers throughout the rest of the world show similar cases per capita.8 Research in this area is extremely important for both upper and lower GI diseases and conditions.

Fighting Against the Curse

This exciting study is an example of observational science. These researchers have used what God has created to engineer an organoid to help fight against conditions and diseases that are a result of the Curse. The ability to do observational science is a great blessing from our Creator, who has made us in his image with a desire to discover, explore, engineer, create, and—in the case of medical research—study ways to alleviate suffering and cure disease.


GI tract conditions and diseases—like all illnesses and diseases—are a result of man’s sin. God’s original creation was “very good” (Genesis 1:31), but sin brought death and suffering into creation. But God, in His grace, has given us the tools and intellect to fight against the temporary effects of the Curse. However, the only true and lasting solution to the Curse is putting our faith and trust in Jesus Christ and what he’s done for us.

But There’s a Downside

Not everything about this study is good. We also note that these researchers used both human pluripotent stem cells (hPSCs, derived from adult tissue) and human embryonic stem cells (hESCs).9 The latter kind of stem cells requires the usage and destruction of embryos or embryonic cells. But work with hPSCs is well advanced, and hPSCs are increasingly being used to generate organoids10 because they eliminate the worry of donor rejection.11 Most importantly, hPSCs don’t destroy human life. It seems as if hESCs could (and should) have been avoided.

Generating organoids by using hPSCs to fight against diseases and illnesses has the potential to help millions of people. But using hESCs crosses a major ethical line—it takes the life of a human being. Destroying embryos—which biblically (Psalm 139:13–14; Jeremiah 1:5) and scientifically are fully human—to use their cells for research is murder. Perhaps there is a noble purpose to the research, as in this case, but at what cost? At the cost of human life, sacrificed for science! Time, energy, and money would be much better spent on researching how to use hPSCs—which have shown great promise—to accomplish the very same thing without the ethical implications of destroying a human being.

Until That Day Comes

There is a day coming when all sin, death, suffering, pain, and tears will be done away with (Revelation 21:4). Until that day, researchers and scientists can use what God has created, with God’s Word as their moral guide and the foundation for their thinking, to combat the effects of the Curse for his glory and the betterment of mankind.


  1. Cincinnati Children’s Hospital Medical Center, “Lab-Grown Human Colons Change Study of Gi Disease,” ScienceDaily, June 22, 2017, https://www.sciencedaily.com/releases/2017/06/170622122000.htm.
  2. For a more complete definition, please see Alexey Bersenev, “Defining of Organoids,” Stem Cell Assays, November 4, 2014, http://stemcellassays.com/2014/11/defining-organoids/.
  3. These are adult stem cells (not embryonic stem cells) which can differentiate to produce cells or tissue the body needs to repair itself.
  4. SATB2 stands for Special AT-Rich Sequence-Binding Protein 2.
  5. BMP stands for Bone Morphogenetic Protein.
  6. “Digestive Diseases Statistics for the United States,” National Institute of Diabetes and Digestive and Kidney Diseases, https://www.niddk.nih.gov/health-information/health-statistics/digestive-diseases.
  7. “Gastrointestinal: Disorders, Facts & Information,” Disabled World, March 11, 2015, https://www.disabled-world.com/health/digestive/.
  8. “Coping with Common GI Symptoms in the Community,” World Gastroenterology Organisation, May 2013, http://www.worldgastroenterology.org/guidelines/global-guidelines/common-gi-symptoms/common-gi-symptoms-english.
  9. Jorge O. Munera et al., “Differentiation of Human Pluripotent Stem Cells into Colonic Organoids via Transient Activation of BMP Signaling,” Cell Stem Cell 21, no. 1 (2017): https://www.ncbi.nlm.nih.gov/pubmed/28648364.
  10. Megan Scudellari, “How iPS Cells Changed the World,” Nature, June 15, 2016, http://www.nature.com/news/how-ips-cells-changed-the-world-1.20079.
  11. Charles A. Goldthwaite, “The Promise of Induced Pluripotent Stem Cells (iPSCs),” National Institutes of Health, https://stemcells.nih.gov/info/Regenerative_Medicine/2006Chapter10.htm.




The ART Bill has come in close succession after the Surrogacy Bill 2019 and the Medical Termination of Pregnancy Amendment Bill 2020. The ART Bill is intended to be a regulatory mechanism. The state boards will have the responsibility to oversee policies. It will also assist the National Board in it’s functioning.

India which has highly skilled doctors, well equipped Hospitals with latest technologies, and comparatively reduced cost has been a desired destination for Medical tourism pertaining to infertility as a wide range of options are readily available, including surrogacy.

Earlier efforts to regularize the ART facilities seem to have had limited success. One will need to wait and see how the ART Bill will be implemented to achieve its goals.


Union Cabinet Clears Bill to Regulate Assisted Reproductive Technology Facilities

https://www.news18.com/news/india/union-cabinet-clears-bill-to-regulate-assisted-reproductive-technology-facilities-2507683.html cited on 20.2.2020

'The Immortal Life of Henrietta Lacks' will be shown in HBO channel on April 22 at 8PM.

Those dealing with biological samples should watch this to understand ethical implications involved.



Bioethicists have called for a ban on using a new pre-natal test to determine the sex of a baby, because it may lead to more 'gender-abortions'.

Non-invasive pre-natal testing (NIPT) has already come under fire because of its aim to 'screen out' babies with Down's Syndrome.

Now the Nuffield Council on Bioethics, a government-backed think-tank, is warning that private clinics are offering NIPT to women to determine the sex of their baby.

What is NIPT?

NIPT screens a pregnant mother's blood for tiny fragments of DNA. These fragments are then checked at between 11 and 14 weeks of pregnancy for abnormalities

It was designed to detect certain conditions in unborn babies, such as Down's, Edward's and Patau's syndrome, and is set to replace the current method of testing, amniocentesis, which is more invasive and carries a small risk of miscarriage.

What's wrong with NIPT?

Serious concerns have been raised that more mothers will choose to abort their child on the basis of the diagnosis.

Currently, 9 in 10 mothers  who are told that their baby will have Down's choose to abort. It is believed that this number will increase when NIPT is offered on the NHS next year.

In Iceland, similar tests have resulted in no more babies with Down's being born in the country.

'Gender-abortion' fears 

Now there are fresh concerns that the test will also be used to 'screen out' babies if they are not the parents' preferred sex.

Professor Tom Shakespeare, chair of Nuffield Council on Bioethics' working group on NIPT, said: "We strongly believe there should be a ban on its use to find out the sex of the fetus, as this could lead to sex-selective abortions."

Parents are usually offered the chance to find out the sex of their child at 20 weeks' gestation.

Professor Shakespeare said: "Very few people will decide to have an abortion at that stage of the pregnancy.

"But at 10 weeks an abortion is much easier."

Aisling's bid for 'gender-abortion' justice 

The disturbing allegation that 'gender-abortions' are taking place in the UK has been raised in the past.

In 2012, two doctors were filmed by undercover investigators from the Telegraph, separately offering abortions to a pregnant woman simply because she said the baby was a girl.

But the Crown Prosecution Service claimed that it was not in the 'public interest' to prosecute.

Christian Legal Centre client Aisling Hubert then brought private prosecutions against the doctors, but the CPS took over the case and dropped it, leaving her with a huge legal bill to pay.

Watch Aisling's story.

23-year-old Aisling needs help to pay these costs, awarded against her simply for pursuing justice for unborn baby girls.

Help her meet these costs by donating to the Christian Legal Centre.